Progressive Changes in Brain Morphology in People With Idiopathic Generalized Epilepsy

Area of Science:

• Neuroimaging
• Epileptology
• Neurology

Background:

• Idiopathic generalized epilepsy (IGE) often responds to treatment, but some patients experience persistent seizures despite medication trials.
• Progressive structural brain changes in poorly controlled chronic IGE are not well understood.
• This study investigates longitudinal brain alterations in early-stage versus chronic IGE.

Purpose of the Study:

• To determine if poorly controlled chronic IGE is associated with progressive morphological brain changes.
• To compare these changes with those in early-stage IGE.
• To explore potential protective effects of valproate and monitor disease progression.

Main Methods:

• Longitudinal case-control neuroimaging study using T1-weighted MRI scans.
• Two cohorts: early-stage IGE and chronic IGE, with matched healthy controls.
• Analysis of cortical thickness, subcortical volumes, and structural covariance over at least 12 months.

Main Results:

• Early-stage IGE showed putamen atrophy; chronic IGE exhibited widespread cortical thinning and subcortical atrophy (putamen, thalamus, pallidum).
• Generalized tonic-clonic seizures correlated with frontal cortex thinning and precentral gyrus thickening.
• Photosensitive IGE was linked to occipital cortex thickening; valproate use was associated with attenuated structural changes.

Conclusions:

• Chronic IGE, especially with persistent generalized tonic-clonic seizures or photosensitivity, shows significant progressive brain changes.
• Valproate may have a protective role in mitigating these structural alterations.
• Longitudinal MRI is a valuable tool for tracking disease progression and treatment efficacy in IGE.